Michelle Lenarduzzi, Ph.D.
Affiliations: | 2013 | Medical Biophysics | University of Toronto, Toronto, ON, Canada |
Area:
Cell Biology, Molecular Biology, OncologyGoogle:
"Michelle Lenarduzzi"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Fei-Fei Liu | grad student | 2013 | University of Toronto | |
| (Investigating Novel Biological Mechanisms of Head and Neck Cancers.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lenarduzzi M, Hui AB, Yue S, et al. (2013) Hemochromatosis enhances tumor progression via upregulation of intracellular iron in head and neck cancer. Plos One. 8: e74075 |
| Lenarduzzi M, Hui AB, Alajez NM, et al. (2013) MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1. Plos One. 8: e53765 |
| Alajez NM, Shi W, Wong D, et al. (2012) Lin28b promotes head and neck cancer progression via modulation of the insulin-like growth factor survival pathway. Oncotarget. 3: 1641-52 |
| Alajez NM, Lenarduzzi M, Ito E, et al. (2011) MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Research. 71: 2381-91 |
| Alajez NM, Shi W, Hui AB, et al. (2010) Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death & Disease. 1: e85 |
| Hui AB, Lenarduzzi M, Krushel T, et al. (2010) Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1129-39 |